Evidence map›Paper›PMID 35809572›Full record

ArticleMolecular cell2022

Recognition of HIV-1 capsid by PQBP1 licenses an innate immune sensing of nascent HIV-1 DNA.

Sunnie M Yoh, João I Mamede, Derrick Lau, Narae Ahn, Maria T Sánchez-Aparicio, Joshua Temple, Andrew Tuckwell, Nina V Fuchs, Gianguido C Cianci, Laura Riva and 11 more

Open access · greenAbstract read
In one paragraph

Article in Molecular cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Blockade ofmBio · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 8 institutions in 3 countries.

Sunnie M YohDepartment of Immunology and Microbiology, Scripps Research, La Jolla, CA 92037, USA. Electronic address: syoh@scripps.edu.
João I MamedeDepartment of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA; Department of Microbial Pathogens and Immunity, Rush University Medical Center, Chicago, IL 60612, USA.
Derrick LauEMBL Australia Node in Single Molecule Science, School of Medical Sciences, University of New South Wales, Sydney, Australia.
Narae AhnDepartment of Immunology and Microbiology, Scripps Research, La Jolla, CA 92037, USA.
Maria T Sánchez-AparicioDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Joshua TempleDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06511, USA.
Andrew TuckwellEMBL Australia Node in Single Molecule Science, School of Medical Sciences, University of New South Wales, Sydney, Australia.
Nina V FuchsHost-Pathogen Interaction, Paul-Ehrlich-Institut, 63225 Langen, Germany.
Gianguido C CianciDepartment of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Laura RivaCalibr, a Division of The Scripps Research Institute, La Jolla, CA 92037, USA.
Heather CurryDepartment of Immunology and Microbiology, Scripps Research, La Jolla, CA 92037, USA.
Xin YinState Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, P.R. China.
Stéphanie GambutDepartment of Microbial Pathogens and Immunity, Rush University Medical Center, Chicago, IL 60612, USA.
Lacy M SimonsDepartment of Medicine, Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA; Center for Pathogen Genomics and Microbial Evolution, Institute for Global Health, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Judd F HultquistDepartment of Medicine, Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA; Center for Pathogen Genomics and Microbial Evolution, Institute for Global Health, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Renate KönigHost-Pathogen Interaction, Paul-Ehrlich-Institut, 63225 Langen, Germany.
Yong XiongDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06511, USA.
Adolfo García-SastreDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Till BöckingEMBL Australia Node in Single Molecule Science, School of Medical Sciences, University of New South Wales, Sydney, Australia.
Thomas J HopeDepartment of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Sumit K ChandaDepartment of Immunology and Microbiology, Scripps Research, La Jolla, CA 92037, USA. Electronic address: schanda@scripps.edu.
EMBL Australia · AUNorthwestern University · USScripps Institution of Oceanography · USYale University · USChinese Academy of Agricultural Sciences · CNIcahn School of Medicine at Mount Sinai · USRush University Medical Center · USScripps Research Institute · US

Funding

UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SUSAN JANET LITTLE · 1994 to 2026
$78.4M
Virology and Immunology Technology CoreP30AI117943 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Sahera Dirajlal-Fargo · 2015 to 2026
$38.4M
Project 3U54AI170792 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Alexander Marson · 2022 to 2026
$35.7M
CHEETAH Center for the Structural Biology of HIV Infection, Restriction, and Viral DynamicsU54AI170856 · NIAID · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI WALTHER H MOTHES · 2022 to 2026
$34.4M
Virus TransmissionP50AI150464 · NIAID · UNIVERSITY OF UTAH · PI HOPE, THOMAS · 2019 to 2021
$14.9M
X-ray Screening and Rapid Structure DeterminationP50AI150476 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI EMERMAN, MICHAEL · 2019 to 2021
$14.4M
Technology Development 2: MAS NMR and dynamic nuclear polarization for HIV-1 structural biologyP50AI150481 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI XIONG, YONG · 2019 to 2021
$14.1M
Functionally Defining HIV-Host Interactions During the Early HIV-1 LifecycleR01AI150998 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI BIENIASZ, PAUL D., HOPE, THOMAS · 2020 to 2024
$6.8M
Innate Immune Surveillance of HIV-1 During Transmission and Systemic InfectionR01AI127302 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI CHANDA, SUMIT K, GARCIA-SASTRE, ADOLFO · 2017 to 2021
$4.4M
A multiscale approach for elucidating nuclear entry mechanisms of HIV-1 capsidR01AI162260 · NIAID · YALE UNIVERSITY · PI LIN, CHENXIANG, XIONG, YONG · 2021 to 2025
$3.5M
Regulation of SAMHD1 antiviral activityR01AI150455 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI DIAZ-GRIFFERO, FELIPE · 2019 to 2024
$3.3M
NCATS NIH HHS UL1 TR001442NIAID NIH HHS K22 AI140963NIAID NIH HHS P30 AI036214NIAID NIH HHS P30 AI117943NIAID NIH HHS P50 AI150464NIAID NIH HHS P50 AI150476NIAID NIH HHS P50 AI150481NIAID NIH HHS R01 AI105184NIAID NIH HHS R01 AI127302NIAID NIH HHS R01 AI150455NIAID NIH HHS R01 AI150998NIAID NIH HHS R01 AI162260NIAID NIH HHS R01 AI165236NIAID NIH HHS U54 AI170792NIAID NIH HHS U54 AI170856NIMH NIH HHS R21 MH129205
6 · The paper itself

Abstract

We have previously described polyglutamine-binding protein 1 (PQBP1) as an adapter required for the cyclic GMP-AMP synthase (cGAS)-mediated innate response to the human immunodeficiency virus 1 (HIV-1) and other lentiviruses. Cytoplasmic HIV-1 DNA is a transient and low-abundance pathogen-associated molecular pattern (PAMP), and the mechanism for its detection and verification is not fully understood. Here, we show a two-factor authentication strategy by the innate surveillance machinery to selectively respond to the low concentration of HIV-1 DNA, while distinguishing these species from extranuclear DNA molecules. We find that, upon HIV-1 infection, PQBP1 decorates the intact viral capsid, and this serves as a primary verification step for the viral nucleic acid cargo. As reverse transcription and capsid disassembly initiate, cGAS is recruited to the capsid in a PQBP1-dependent manner. This positions cGAS at the site of PAMP generation and sanctions its response to a low-abundance DNA PAMP.

Indexed as

HIV-1CapsidDNADNA-Binding ProteinsHumansImmunity, InnateNucleotidyltransferasesPathogen-Associated Molecular Pattern MoleculesDNADNA-Binding ProteinsNucleotidyltransferasesPathogen-Associated Molecular Pattern MoleculesPQBP1 protein, humancGASHIV-1 capsidinnate sensingPQBP1two-factor authenticationuncoating

Identifiers

PMID35809572
PMCPMC9552964
OpenAlexW4284974949

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.